121. Recommendations to reduce the possible risk of transmission of Creutzfeldt-Jakob disease and variant Creutzfeldt-Jakob disease by blood and blood components Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, May 2022 Subject(s): Blood Component Transfusion -- legislation & jurisprudenceCreutzfeldt-Jakob Syndrome -- prevention & controlUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
122. Safety considerations for container labels and carton labeling design to minimize medication errors Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2022 Subject(s): Drug Labeling -- legislation & jurisprudenceMedication Errors -- prevention & controlPatient SafetyUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
